Datavault AI (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. to extend its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan and wellness applications. The expanded relationship is designed to support patient-controlled health data access, monetization and real-world asset tokenization across pharmacy, medical, laboratory and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
This expansion is significant because it positions Datavault AI at the intersection of blockchain, AI, and healthcare, a sector ripe for digital transformation. By enabling patients to control and monetize their own health data through tokenization, the company is tapping into a paradigm shift toward decentralized health data management. The global health and wellness market, valued at trillions of dollars, presents a massive opportunity for companies that can securely and efficiently manage sensitive health information while giving individuals ownership of their data.
The integration of Datavault AI’s technology with DataMEDS’ PharmacyChain could streamline medical logistics, reduce fraud in pharmaceutical supply chains, and enhance remote patient monitoring through AI-driven analytics. This move also aligns with broader trends in Web 3.0, where real-world assets are tokenized and traded on blockchain networks, potentially creating new revenue streams for patients and providers alike.
For the full press release, visit https://ibn.fm/vBAxH. Datavault AI’s latest news and updates are available in the company’s newsroom at https://ibn.fm/DVLT.
